David Brennan, AstraZeneca CEO, looks at the company's results including Results and financial performance, medicines and pipeline and outlook and strategy.
AstraZeneca's Susan Galbraith, Head of Oncology Innovative Medicines Unit, talks about the current focus areas in cancer treatment and the importance of collaborations to help...
Human bodies and developing new medicines is big business. As its latest blood-thinning blockbuster, Brilinta, finally hits US pharmacy shelves, is AstraZeneca undervalued or over...
Video interview series with global leaders by Russell Reynolds Associates: bit.ly Former AstraZeneca CEO David Brennan on effective growth strategies, the role of the board...